4//SEC Filing
Regulus Therapeutics Inc. 4
Accession 0001209191-17-041644
CIK 0001505512operating
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 4:22 PM ET
Size
5.4 KB
Accession
0001209191-17-041644
Insider Transaction Report
Form 4
Deeg Mark Albert
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-06-22+100,000→ 100,000 totalExercise: $0.99Exp: 2017-06-21→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]25% of the shares vest on June 22, 2018 and the remainder of the shares vest in equal installments on a monthly basis thereafter, such that the option is fully vested on June 22, 2021.
Documents
Issuer
Regulus Therapeutics Inc.
CIK 0001505512
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001505512
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 4:22 PM ET
- Size
- 5.4 KB